Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Exp Immunol ; 80(3): 444-7, 1990 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2372992

RESUMO

The influence of interleukin-1 (IL-1) upon leucocyte locomotion in vitro was studied, using either casein or zymosan-activated serum (ZAS) as chemotaxigens. A pre-incubation of polymorphonuclear cells (PMNC) with ultrapure (purity 99%) human IL-1 (1 U/ml) for 2 and 5 h followed by a washing step resulted in a significant decrease in leucocyte locomotion against casein (P less than 0.0005 and P less than 0.01, respectively), but not against ZAS (P greater than 0.1). Moreover, the direct addition of this IL-1 preparation to leucocyte locomotion assays without pre-incubation produced a similar and significant inhibition of leucocyte locomotion directed against casein (P less than 0.05). This inhibitory effect could not be augmented further by higher concentrations of ultrapure IL-1. In order to exclude the effect of possibly contaminating cytokines in the ultrapure IL-1 preparation used, additional assays with recombinant human IL-1 (rIL-1) alpha and rIL-1 beta (1 U/ml) were performed to investigate their influence upon leucocyte locomotion. It was found that both rIL-1 alpha and rIL-1 beta inhibited leucocyte locomotion directed against casein significantly (P less than 0.005). Similar to the previous experiments, leucocyte locomotion could not be further inhibited by higher concentrations (10 U/ml) or rIL-1. Thus, both ultrapure and rIL-1 were found to have the ability to inhibit leucocyte locomotion in vitro.


Assuntos
Quimiotaxia de Leucócito , Interleucina-1/imunologia , Caseínas/farmacologia , Células Cultivadas , Humanos , Interleucina-1/farmacologia , Neutrófilos/fisiologia , Zimosan/farmacologia
2.
Acta Chir Belg ; 89(4): 185-8, 1989.
Artigo em Inglês | MEDLINE | ID: mdl-2800852

RESUMO

The authors report four arterial aneurysms seen in three patients infected by HIV. The aneurysms affected: 1) the left common carotid artery in a young man HIV carrier, 2) the right common carotid artery and the abdominal aorta in a woman with AIDS, 3) the right common carotid artery in a patient with AIDS-related complex. The aetiology was found to be infectious, respectively: 1) staphylococcus epidermidis (certain), 2) tuberculosis or another undetected infection (possible), 3) staphylococcus epidermidis or syphilis (highly probable). A viral arteritis mechanism is also postulated in the second case. If this association of aneurysms with HIV infection is not fortuitous, an increase of aneurysm incidence in HIV infected population is to be expected.


Assuntos
Síndrome da Imunodeficiência Adquirida/complicações , Aneurisma/complicações , Doenças das Artérias Carótidas/complicações , Complexo Relacionado com a AIDS/complicações , Adulto , Aorta Abdominal , Aneurisma Aórtico/complicações , Feminino , Soropositividade para HIV/complicações , Humanos , Masculino , Pessoa de Meia-Idade
3.
Cancer ; 63(10): 1985-9, 1989 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-2702570

RESUMO

Tumor-bearing patients with breast cancer were assayed for their natural killer (NK) cell activity and for the function of activated cytotoxic T-cells, as assessed by lectin-dependent cellular cytotoxicity (LDCC). Tumor-bearing patients with breast cancer had a significant increase in NK activity and in LDCC, as compared with healthy control individuals. Although the enhanced NK cell activity and LDCC were closely associated with high levels (greater than 31 fmol/mg) of estrogen receptor (ER) content in the primary tumor, no other clinical or histologic correlation between the increase in either parameter of cytotoxic effector cell function could be found. Thus, ER levels greater than 31 fmol/mg might be associated with increased cytotoxic effector cell function in tumor-bearing patients with breast cancer.


Assuntos
Neoplasias da Mama/imunologia , Citotoxicidade Imunológica , Células Matadoras Naturais/imunologia , Lectinas/imunologia , Receptores de Estrogênio/análise , Neoplasias da Mama/análise , Feminino , Humanos , Prognóstico , Receptores de Progesterona/análise
4.
J Endocrinol ; 121(1): 177-83, 1989 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-2654321

RESUMO

Patients who had been included in a randomized double-blind placebo-controlled trial on the efficacy of cyclosporin A (CyA) in producing remissions in insulin-dependent diabetes mellitus (IDDM) type I were investigated for humoral and cellular immunologic parameters. Whereas metabolic derangement before the initiation of insulin treatment led to small but significant decreases in the percentage of CD4-positive lymphocytes as well as of the activity of natural killer (NK) cells and antibody-dependent cellular cytotoxicity (ADCC), the administration of CyA did not influence any of the immunologic parameters tested, which included proliferative lymphocyte responses to mitogens and alloantigens and serum concentrations of immunoglobulins G, A and M. Thus NK cell activity, ADCC as well as the percentage of CD4-positive lymphocytes returned to normal levels in parallel with the normalization of glycosylated haemoglobin (HbAlc), but were not further influenced in their course by the administration of CyA, as compared with patients receiving placebo. Interferon-induced augmentation of NK cell activity did not differ between patients with IDDM on placebo and those under CyA therapy. All other investigated parameters also remained unchanged during the time of CyA therapy. We conclude that metabolic derangement leads to a reversible disturbance of certain cellular immune functions, but their normalization achieved by insulin treatment and their further course remains uninfluenced by the administration of CyA.


Assuntos
Ciclosporinas/uso terapêutico , Diabetes Mellitus Tipo 1/imunologia , Adolescente , Adulto , Ensaios Clínicos como Assunto , Citotoxicidade Imunológica/efeitos dos fármacos , Diabetes Mellitus Tipo 1/tratamento farmacológico , Método Duplo-Cego , Feminino , Seguimentos , Hemoglobinas Glicadas/metabolismo , Humanos , Imunoglobulinas/análise , Células Matadoras Naturais/imunologia , Ativação Linfocitária/efeitos dos fármacos , Linfócitos/classificação , Masculino , Distribuição Aleatória
5.
Arzneimittelforschung ; 35(6): 991-3, 1985.
Artigo em Inglês | MEDLINE | ID: mdl-4026928

RESUMO

This study examines the pharmacokinetics of lipophilic drug doxycycline (Vibramycin) and water-soluble antibiotic oxytetracycline hydrochloride (Oxyterracyna) in patients with hyperlipidemia type IIa and type IV according to Fredrickson. Antibiotics were administered orally as a single dose and determined in plasma by a fluorimetric method. The calculations were performed by aid of a computer. Increased concentrations of doxycycline were found; they were higher in type IIa, as compared with type IV. Area under the curve (AUC) and peak concentrations as well as rate constant for elimination in subjects with type IV were significantly elevated; volumes of distribution and total body clearance were markedly diminished. Decreased concentrations of oxytetracycline, area under the curve, peak concentration and rate constant for elimination were observed in patients with type IV. In both types of hyperlipidemia volume of distribution was increased and half-life in patients with type IV was significantly prolonged. The findings show that hyperlipidemia can be an important factor of drug action. Alterations of pharmacokinetics of lipophilic doxycycline and hydrophilic oxytetracycline were contrasting.


Assuntos
Doxiciclina/metabolismo , Hiperlipidemias/metabolismo , Oxitetraciclina/metabolismo , Adulto , Doxiciclina/sangue , Humanos , Cinética , Masculino , Pessoa de Meia-Idade , Oxitetraciclina/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...